Leading HIV Researchers and Argos Therapeutics, Inc. Highlight Importance of Immunotherapy in HIV Eradication Efforts

Published: Jun 13, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DURHAM, N.C., June 13, 2013 (GLOBE NEWSWIRE) -- In conjunction with the U.S. Food and Drug Administration's (FDA) June 14th Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research, leading HIV researchers and Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, today highlighted the role of immunotherapy in potential HIV eradication studies.

Help employers find you! Check out all the jobs and post your resume.

Back to news